Skip to main content

Table 3 “Non-criteria” clinical manifestations present in the seronegative antiphospholipid syndrome group

From: The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

Clinical manifestation

 

Non-obstetric (n, %)

n= 82

 Migraine

23 (28.0)

 Brain MRI white matter lesions

21 (25.6)

 Superficial vein thrombosis

19 (23.2)

 Thrombocytopenia

17 (20.7)

Livedo reticularis

10 (12.2)

 Valvular heart disease

8 (9.8)

 Raynaud’s phenomenon

6 (7.3)

 Seizures

6 (7.3)

 Coombs’ positivity

5 (6.1)

 Memory lapses

5 (6.1)

 Transverse myelitis

3 (3.7)

 Hemolytic anemia

3 (3.7)

 Cognitive dysfunction

3 (3.7)

 Pseudo-multiple sclerosis

3 (3.7)

 Cardiac microvascular disease

3 (3.7)

 Skin ulcers

2 (2.4)

 APS nephropathy

2 (2.4)

 Livedoid vasculopathy

1 (1.2)

Obstetric

n= 66

 Two spontaneous abortions <10 weeks

11 (16.7)

 Late IUGR (>34 weeks)

5 (7.6)

 Infertility

4 (6.1)

 Premature birth between 34 and 37 weeks

3 (4.5)

 Placental abruption

3 (4.5)

 ≥ 2 or more IVF failures

2 (3.0)

 Puerperal preeclampsia

1 (1.5)

 Late preeclampsia (>34 weeks)

1 (1.5)

 Placental hematoma

1 (1.5)

 Puerperal Thrombosis

1 (1.5)

  1. APS Antiphospholipid syndrome, IUGR Intrauterine growth restriction, IVF In vitro fertilization, MRI Magnetic resonance imaging